Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Biotechnology guaranteed US$ 100 K to average Brazilian corn growers in four years, according to ABRASEM


News provided by

ABRASEM

22 Jan, 2013, 17:40 GMT

Share this article

Share toX

Share this article

Share toX

- A 50-hectare property can earn up to US$ 324,000 more in 10 years

- Study updates economic and social-environmental benefits of adopting transgenics, with reduced water use and pesticide application

SAO PAULO, Jan. 22, 2013 /PRNewswire/ -- The Associacao Brasileira de Sementes e Mudas (ABRASEM – Brazilian Association of Seeds and Seedlings) has released the sixth edition of studies by Celeres and Celeres Ambiental on the economic and social-environmental impacts of the adoption of biotechnology on Brazilian crops.  According to the analysis, the grower of a crop of 50 hectares of insect-resistant corn has already earned an additional return of up to US$ 100,400 since this technology was commercialized in Brazil. The projection is that over the next ten years, this same grower will see an increase of US$ 324,100 in earnings, chiefly due to the increase of productivity that the technology provides.

Evaluating the overall picture for biotechnology in Brazil, taking into account the three crops with transgenic varieties that have already been approved and are in commercial production – corn, soybeans and cotton – the results are also significant.  With the prospect of the approval of new technologies, greater adoption by growers and enhancements of the existing technology, the total economic benefit from the adoption of transgenics in the next ten years should come to US$ 118.2 billion, with 82% of this amount going to the grower.

"ABRASEM has sought to bring results closer to the reality of Brazilian farmers, primarily family farms," explains farmer and ABRASEM President, Narciso Barison Neto.

ABRASEM's infographic shows the benefits of biotechnology in the Brazilian agriculture (Click to access)

Productivity gains yield good results and stimulate competitiveness

Another highlight of the study has to do with gains in productivity, which turned out to be the key factor in economic benefits generated for growers, surpassing the reduction of production costs, which had been the dominant factor in earlier studies. This change could also be attributed to the good results for agriculture accruing from the adoption of transgenic corn.

"Analyzing the economic results that the adoption of biotechnology has achieved for Brazilian agriculture in the last 16 years, as well as prospects for the next ten years, it becomes essential to improve and continue to oversee public policies to ensure a favorable environment for the development of biotechnology in Brazil," explains Anderson Galvao, managing partner at Celeres and coordinator of the economic study.

To the President of ABRASEM, the study shows that investment in biotechnology is good for growers. "And this is all the more important when we think of keeping up the competitiveness of national agricultural production, at a time when expectations of growing world demand for food are taking over the local and international discussion," he notes.  

"The case of corn is the most striking example of the leap in profitability and environmental impact that biotechnology can offer to growers.  And the impacts of this adoption are even more discernible for small and medium growers, whose competitiveness is improving," Barison adds.

Read the entire study on economic benefits (link to Celeres site)

Read the entire study on social-environmental benefits (link to Celeres site)

Environmental benefits

The study also presents the benefits of biotechnology for the environment and the sustainability of Brazilian agribusiness over the past 16 years – since the arrival of the first genetically modified seeds in Brazil – as well as for the next ten years, taking into consideration factors such as water use, diesel consumption, carbon emissions and the use of pesticides.

The projected benefit with regard to water use for the period from 2012/13 to 2021/22 is 167.4 billion liters of water that would cease to be used on crops with the adoption of biotechnology.  This volume could supply a population of 3.8 million people.

The amount of diesel fuel used in agricultural machinery for transgenic crops will also see a significant reduction over the next ten years that could be as high as 1.4 billion liters, enough to supply a fleet of 581,200 light vehicles. For carbon emissions resulting from the use of diesel oil, it is projected that about 3.7 million tons of CO2 would not be released into the atmosphere, which is the equivalent of preserving 27.3 million trees.

"The level of benefits increases as growers accelerate the adoption of biotechnology, a tool that is capable of contributing more sustainable farming practices that reduce pressure on natural resources," explains Paula Carneiro, director of Celeres Ambiental and coordinator of the social-environmental study.

Study reaches sixth edition

This is the sixth edition of a study monitoring the benefits of biotechnology for Brazilian agriculture, which has been conducted annually for ABRASEM since 2008.  The evaluation is divided between economic benefits, analyzed by Celeres, and social-environmental benefits, addressed by Celeres Ambiental. These companies are the only ones in Brazil that regularly monitor the adoption of transgenics in agriculture – and have been doing so from the start. The results are based on field research and interviews with more than 360 growers of soybeans, corn and cotton scattered all over the country. These are the three crops in Brazil with approved GM events that are already available on the market.  

Infographic helps to understand how much technology is there in a single seed (Click to access)

Contacts for the press:

Barcelona Solucoes Corporativas
Rafaela Prieto 
+55 (11) 3019-3092 
rafaela@barcelonasolucoes.com.br

Bruno Viecili 
+55 (11) 3019-3091 
bruno@barcelonasolucoes.com.br

Monica Giacomini 
+55 (11) 3019-3098 
monica@barcelonasolucoes.com.br

'

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.